기본 정보
- CAS
65350-86-9- 표준 SMILES
CO[C@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1ccc(O)c(O)c1- InChIKey
PDHSAQOQVUXZGQ-JKSUJKDBSA-N- 분자식
- C16H16O6
- 평균 분자량
- 304.29 g/mol
- 단동위원소 질량
- 304.09468823
개요
meciadanol has been reported in Arabidopsis thaliana with data available.
이름 및 식별자
- 우선 이름
- Meciadanol
- IUPAC
- (2R,3S)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2H-chromene-5,7-diol
- 영어명
- (2R-trans)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-methoxy-2H-1-benzopyran-5,7-diol
- 분자식
- C16H16O6
- 분자량
- 304.29
이름 및 동의어
MECIADANOL65350-86-93-O-methylcatechinMeciadanolum2H64SE2UXS(2R,3S)-2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2H-chromene-5,7-diol(2R,3S)-3-Methoxy-3',4',5,7-flavantetrolDTXSID2010243522-Methoxy-5,7,3',4'-tetrahydroxyflavan3-Mthf3',4',5,7-Tetrahydroxy-3-methoxyflavanRefChem:156201
이름 더 보기
Zy-150292-(3,4-dihydroxyphenyl)-3-methoxy-chromane-5,7-diol2-(3,4-dihydroxyphenyl)-3-methoxy-3,4-dihydro-2H-chromene-5,7-diol(2R)-2α-(3,4-Dihydroxyphenyl)-3,4-dihydro-3β-methoxy-2H-1-benzopyran-5,7-diol(2R,3S)-2α-(3,4-Dihydroxyphenyl)-3,4-dihydro-3β-methoxy-2H-1-benzopyran-5,7-diol(2R-trans)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-methoxy-2H-1-benzopyran-5,7-diol2H-1-Benzopyran-5,7-diol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-methoxy-, (2R,3S)-
2H-1-Benzopyran-5,7-diol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-3-methoxy-DTXCID201508564265-710-7Meciadanol [INN](2R,3S)-2-(3,4-Dihydroxyphenyl)-3-methoxychroman-5,7-diolMeciadanolum [Latin]UNII-2H64SE2UXS(2R,3S)-2-(3,4-DIHYDROXYPHENYL)-3-METHOXY-3,4-DIHYDRO-2H-1-BENZOPYRAN-5,7-DIOL
데이터베이스 식별자
- CAS
65350-86-9- PubChem CID
- 10380295
- DTXSID
DTXSID201024352- ChEMBL
CHEMBL2106853- UNII
- 2H64SE2UXS
- EC Number
- 265-710-7
- Nikkaji
- J23.011A
물성
구조 계산 물성
- XLogP
- 0.9
- 극성 표면적
- 99.4 Ų
- 수소 결합 공여자 수
- 4
- 수소 결합 수용자 수
- 6
- 회전 가능 결합 수
- 2
- 무거운 원자 수
- 22
- 형식 전하
- 0
- 복잡도
- 378
실험 및 물리화학적 성질
LogP1.0
Endocrine DisruptorsPotential endocrine disrupting compound
화학 및 산업
약리 정보
MeSH Pharmacological Classification
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Cellular LocationsCytoplasm
공급사1 곳
Lanospharma Laboratories Co.,Ltd13440048448 · [email protected]
관련 반응
1건
화합물 노트
불러오는 중…